K. Kusumoto et al., ROLE OF ENDOGENOUS ENDOTHELIN IN EXTENSION OF RABBIT MYOCARDIAL-INFARCTION, Journal of cardiovascular pharmacology, 22, 1993, pp. 190000339-190000342
The role of endogenous endothelin-1 (ET-1) in myocardial infarction wa
s investigated in a rabbit ischemia-reperfusion model and in rabbit La
ngendorff hearts. AwETN40, a monoclonal antibody against ET-1, at 10 m
g/kg i.v. inhibited hypertension and hypotension induced by ET-1 (0.3
nmol/kg i.v.): about 70-100% inhibition lasted for 24 h. In a coronary
occlusion (30 min)-reperfusion (24 h) model, AwETN40 (10 mg/kg i.v.)
reduced the infarct size from 60.9 +/- 4.6% (infarct region/ischemic r
egion in weight, IgG1kappa control; n = 5) to 37.1 +/- 5.2% (n = 5, p
< 0.05). Plasma ET-1 levels were increased significantly by coronary o
cclusion-reperfusion and returned to control level 24 h after reperfus
ion. Effects of ET-1 on the coronary vessels and cardiac contractility
were studied in the Langendorff heart. ET-1 increased the perfusion p
ressure from concentrations as low as 10 pM, whereas the developed lef
t ventricular pressure was not altered. These results suggest that ET-
1 decreases oxygen supply to the cardiac muscles by constricting coron
ary vessels and that this, in turn, worsens the ischemic condition of
the heart to extend the infarct size.